Home > Insider Trading > Filing (0000899243-21-014868)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1809519	Goodrx Holdings Inc.	GDRX	Services-Computer Processing & Data Preparation (7374)	475104396

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1822193	Babak Azad	C/O Goodrx Holdings, Inc. 2701 Olympic Boulevard Santa Monica CA 90401	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2021-04-01	21,250	$5.94	21,250	No	4	M	Direct
Class A Common Stock	Disposition	2021-04-01	10,172	$39.24	11,078	No	4	S	Direct
Class A Common Stock	Disposition	2021-04-01	11,078	$40.06	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-01	21,250	$0.00	21,250	$5.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
578,750		2030-01-30	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.82 to $39.78. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This price reported in Column 4 is a werighted average price. These shares were sold in multiple transactions at prices ranging from $39.84 to $40.52. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on October 9, 2019.